Member Info for Doc83

Manifesto, Polygon managed to get up to 25% extremely cheaply (relative to overall cost). That means they now have some control over what the company does and could potentially/maybe protect somewhat their original costly investment.

I do not think they know anything more than us. This has already been proven with them getting it wrong like the rest of us.

I think they still have a little bit of hope like us and it was the prudent thing to do to get some control of the company for very little outlay. Hell, if I could afford to take control right now I would!

MrCosts - you will know that I am firmly in the camp that thinks RM (or even SSH) should have done some kind of interview by now. Completely unprecedented for such a major (negative) event to occur and a collapse of the SP with not one person to be physically seen or heard.

But it is what it is. There’s nothing we can do and emailing the company won’t help.

All I will say, is that if an EUA or paid for trials do not transpire, it is a distinct possibility that a cash raise will be needed. Albeit, that might still be a year or two away. Communication is key and even for those that think it is right that the company has gone to ground and stayed silent, there are clearly many who think otherwise. And so those people might not be so willing to stump up more cash if SNG do come calling.

Aether - there are many possibilities and outcomes. But some of them are not good for existing shareholders.

Having owned a few stocks over the years that have a great product but encountered troubles, the outcome for long term loyal shareholders is very often not good. Sirius Minerals springs to mind.

A lot now depends on Polygon who can block anything they like. We need them to have very good intentions for all of our sakes. Unfortunately, they will likely be out for themselves and won’t care what happens to everyone else.

Chance of EUA at this stage must be less than 10%? They really would have to pull a rabbit out of the deep dive data hat for it to stand any chance of happening, IMO.

We’ve just had a disastrous trial. Feet on the ground. Let’s hope for decent ACTIV-2 P2 data and go from there.

@Admin - for goodness sake, please delete Andybe4.

It’s just crazy, I’ve never known a forum where such people don’t get deleted. He is disrupting the board. Will people please just ignore him and not reply to his ramblings.

Burstead - but you just said, we're clutching at straws?

Burstead - why are you here? Genuine question.

You don't seem to appreciate anything that is written and have a very negative outlook for the company?

gggg21 - Good to see you back. Polygon seem to have had ample opportunity to load up. My bet is that they are more or less done at 25%. Will be happy to be proven wrong, though!

Wigster - Great post, especially after having had to read the nonsense posted by Andybe4.

4D Pharma - results look OK, it's a very small study. But crucially the RNS says "Primary Efficacy Endpoint Met", so it deserves its rise today. Oh how I dreamt for Synairgen's P3 RNS to have uttered those words!

For me and Synairgen, I have tempered my expectations massively. "Expect the worst, hope for the best" I think sums me up. I am very much hopeful. But if it goes to £0, I won't be as disappointed as I was on 21/2.

TommyD - it would be great if we could add "stellar ACTIV-2 P2 data" to that list of positives. Hopefully not long now until we find out. I'm hopeful, but it's not nailed on. I was surprised how average SAB's P2 data looked (although I am no expert). I would be very happy to see numbers similar to SPRINTER P2, albeit they are quite different trials.

Thanks, Brand. That sounds encouraging.

Hi Tommy, some serious reading there and I’m out and about. Can you summarise in a few lines what this is saying?

What could be over is Polygon’s buying. They’ve had many opportunities now to increase their holding up from 25% but no TR1 has arrived. We never expected them to go beyond 29.9% but perhaps they think 25% is enough for them. It already gives them enough influence.

Aether, how long is a piece of string? We really can’t answer your question, other than that the share price should be far north (in percentage terms) from where it is currently. Whether that’s 50p, 100p, 500p, we’ll have to wait and see.

Why did they buy another 3%? Probably because it cost them about 72p to do so! :D

I maintain Polygon should not influence your decision whether to invest in Synairgen or not. The three potential positive outcomes I listed are what matters right now. If you think they will be positive, hold the shares. If not, sell. Certainly don’t buy or sell just because they are buying or selling.

Polygon with all their supposed contacts… well, it didn’t work out for them on 21/2.
And as for owning such a large chunk of the company, we can’t control what they decide for Synairgen. But presumably they still want to make money so you have to hope they won’t do anything daft. Unfortunately, it is usually the smaller investor that misses out. My fingers are crossed we don’t get royally screwed somehow.

Aether - I would ignore what Polygon do. Up to this point they have got it horribly wrong like the rest of us..

Our immediate hopes rest on:

- getting on another trial(s).
- SPRINTER P3 deep dive and long Covid analysis throw up some gems.
- ACTIV-2 P2 data being very good.

1 million shares sounds great. But at 20p or so per share it’s less impressive!

Thanks, Gunto.

And yes, I can’t understand why some people come on a BB just to put a stock down repeatedly. :/

Gunto - genuine question and don’t want to fall out, because we are both after the same end result here, but why do you have such faith in Polygon… they’ve got it wrong so far and are 10’s of £millions down?

US SNG OTC price is interesting and a big dislocation from UK price. It usually tracks it quite closely. Equates to about 31p. I’m sure it will correct itself Monday.

Manifesto, just calm it down a bit. Each day you say "someone's buying!". Clearly. But plenty are also selling.

No TR1 from Polygon. If there are wanting to buy up to 29.9%, they are doing it at a snail pace.